Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

about

Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients

P2860

Q36847210-DB1BFA21-8810-47AF-A86B-ADAC651C446D

P2860

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

Item

http://www.wikidata.org/entity/Q37922624

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Effects of dietary factors on lipoprotein-associated phospholipase A

@nl

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

@en

type

Item

label

Effects of dietary factors on lipoprotein-associated phospholipase A

@nl

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

@en

prefLabel

Effects of dietary factors on lipoprotein-associated phospholipase A

@nl

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

@en

P1476

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

@en

P2093

Cheuk-Kit Wong

http://www.w3.org/2001/XMLSchema#string

Harvey D White

http://www.w3.org/2001/XMLSchema#string

P2860

Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males

Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques

Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.

Lp-PLA2: A new target for statin therapy.

Effects of ethanol intake on lipoproteins and atherosclerosis.

The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.

P2888

s11883-011-0201-4

P304

461-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-011-0201-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21870060

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

about

P2860

P2860

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921